Abstract
The objective of the study was to report clinical outcomes and patterns of failure for these patients with cervical esophageal squamous cell carcinoma (CESCC) treated with intensity-modulated radiotherapy (IMRT). A total of 64 patients with CESCC treated with definitive IMRT from May 2005 to March 2012 in our center were analyzed. Forty-two patients received radiotherapy alone and 22 patients received concurrent chemoradiotherapy. The location and extent of locoregional failures were transferred to the pretreatment planning computed tomography for dosimetry analysis. For all patients, the overall 2-year local failure-free survival, regional failure-free survival, distant failure-free survival, and overall survival rate was 74.5, 88.0, 66.6 and 42.5 %, respectively. Twenty-eight patients had developed treatment failure. Of the 28 patients, 14, 5, and 18 had developed local failure, regional failure, and distant metastasis, respectively. All of the 14 local failures were considered in-field failures. Of the five regional failures, three were considered in-field failures and two were marginal failures. The most frequently observed acute toxicity was mainly Grade 1 or 2. The incidence of acute Grade 3 mucositis (including pharyngitis), skin reaction, and leukopenia was 4.7, 12.5 and 10.9 %, respectively. IMRT provides satisfactory locoregional control for CESCC. Distant metastasis remains the predominate pattern of failure and the predominate pattern of locoregional failures is in-field failure.
Similar content being viewed by others
References
Mendenhall WM, Sombeck MD, Parsons JT et al (1994) Management of cervical esophageal carcinoma. Semin Radiat Oncol 4:179–191
Triboulet JP, Mariette C, Chevalier D et al (2001) Surgical management of carcinoma of the hypopharynx and cervical esophagus : analysis of 209 cases. Arch Surg 136:1164–1170
Nishimaki T, Kanda T, Nakagawa S et al (2002) Outcomes and prognostic factors after surgical resection of hypopharyngeal and cervical esophageal carcinomas. Int Surg 87:38–44
Kakegawa T, Yamana H, Ando N (1985) Analysis of surgical treatment for carcinoma situated in the cervical esophagus. Surgery 97:150–157
Tong DK, Law S, Kwong DL et al (2011) Current management of cervical esophageal cancer. World J Surg 35:600–607
Mendenhall WM, Parsons JT, Vogel SB et al (1988) Carcinoma of the cervical esophagus treated with radiation therapy. Laryngoscope 98:769–771
Stuschke M, Stahl M, Wilke H, Oldenburg AR, Stüben G et al (1999) Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical esophagus. Oncology 57:99–105
Burmeister BH, Dickie G, Smithers BM et al (2000) Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Arch Otolaryngol Head Neck Surg 126:205–208
Yamada K, Murakami M, Okamoto Y et al (2006) Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol 45(8):1120–1125
Wang S, Liao Z, Chen Y et al (2006) Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single- institution experience. J Thorac Oncol 1(3):252–259
Huang SH, Lockwood G, Brierley J et al (2008) Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys 71(3):735–740
Grass GD, Cooper SL, Armeson K et al (2014) Cervical esophageal cancer: a population-based study. Head Neck. doi:10.1002/hed.23678
Fenkell L, Kaminsky I, Breen S et al (2008) Dosimetric comparison of IMRT vs 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol 89:287–291
Wang L, Han C, Zhu SC et al (2006) Dosimetry study on conventional and three dimensional conformal radiotherapy for esophageal cancer. Chin J Radiat Oncol 15(3):176–180
Wang SL, Liao Z, Liu H et al (2006) Intensity- modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 12:5501–5508
Dawson LA, Anzai Y, Marsh L et al (2000) Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46:1117–1126
Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174
Zhang Z, Liao Z, Jin J et al (2005) Dose-response relationship in local-regional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61:656–664
Dinshaw KA, Agarwal JP, Ghosh-Laskar S et al (2006) Radical radiotherapy in head and neck squamous cell carcinoma: an analysis of prognostic and therapeutic factors. Clin Oncol (R Coll Radiol) 18(5):383–389
Sun DR (1989) Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. Int J Radiat Oncol Biol Phys 16:329–334
Herskovic A, Martz K, al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326(24):1593–1598
Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01) Radiation Therapy Oncology Group. JAMA 281:1623–1627
Pignon JP, le Maître A, Bourhis J (2007) Meta-analyses of chemotherapy in head and neck cancer (MACH-NC):an update. Int J Radiat Oncol Biol Phys 69(2 Suppl):S112–S114
Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cao, Cn., Luo, Jw., Gao, L. et al. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma: clinical outcomes and patterns of failure. Eur Arch Otorhinolaryngol 273, 741–747 (2016). https://doi.org/10.1007/s00405-015-3576-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-015-3576-y